Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Bleeding Disorder Referrals to Hematology Clinic: A single institution experience

View through CrossRef
Introduction The evaluation for an inherited bleeding disorder can be challenging. Our hematology clinic receives hundreds of referrals annually for bleeding disorder evaluation due to bleeding symptoms and secondary to preoperative laboratory testing. Aim To characterize hematology referrals for bleeding disorder evaluation at our institution. To describe the diagnostic outcomes, estimate the proportion diagnosed, and identify referral factors that are associated with being diagnosed with a bleeding disorder. Methods This is a single center, retrospective chart review. Patients referred and or seen for a bleeding disorder evaluation from 07/1/2018 until 06/30/19 were included. AIC was applied to logistic regression to identify factors associated with diagnosis of bleeding disorder. Results Of the 373 subjects included, mean (SD) age was 8.3 (5.4) years, 210 (56.3%) female, 256 (69%) white and 69 (18%) black; 40 (11%) were diagnosed with a bleeding disorder and 255 ruled out. Of our referred sample, 6% (21/373) were diagnosed with von Willebrand disease, 4% (14/373) with a platelet function disorder, and 1% (4/373) with a coagulation factor deficiency. Forty percent of referrals were for preoperative clearance, 36% for family history, and 57% for symptoms. The odds of a bleeding disorder diagnosis decreased by 8% for every year increase in age and were 3 times higher among patients having abnormal coagulation labs at the time of referral as compared to their counterparts. Conclusion This study highlights predictive variables for the presence of an inherited bleeding disorder. These results may contribute to future large-scale studies.
Title: Bleeding Disorder Referrals to Hematology Clinic: A single institution experience
Description:
Introduction The evaluation for an inherited bleeding disorder can be challenging.
Our hematology clinic receives hundreds of referrals annually for bleeding disorder evaluation due to bleeding symptoms and secondary to preoperative laboratory testing.
Aim To characterize hematology referrals for bleeding disorder evaluation at our institution.
To describe the diagnostic outcomes, estimate the proportion diagnosed, and identify referral factors that are associated with being diagnosed with a bleeding disorder.
Methods This is a single center, retrospective chart review.
Patients referred and or seen for a bleeding disorder evaluation from 07/1/2018 until 06/30/19 were included.
AIC was applied to logistic regression to identify factors associated with diagnosis of bleeding disorder.
Results Of the 373 subjects included, mean (SD) age was 8.
3 (5.
4) years, 210 (56.
3%) female, 256 (69%) white and 69 (18%) black; 40 (11%) were diagnosed with a bleeding disorder and 255 ruled out.
Of our referred sample, 6% (21/373) were diagnosed with von Willebrand disease, 4% (14/373) with a platelet function disorder, and 1% (4/373) with a coagulation factor deficiency.
Forty percent of referrals were for preoperative clearance, 36% for family history, and 57% for symptoms.
The odds of a bleeding disorder diagnosis decreased by 8% for every year increase in age and were 3 times higher among patients having abnormal coagulation labs at the time of referral as compared to their counterparts.
Conclusion This study highlights predictive variables for the presence of an inherited bleeding disorder.
These results may contribute to future large-scale studies.

Related Results

Bleeding Disorder Referrals to Hematology Clinic: A Single Institution Experience
Bleeding Disorder Referrals to Hematology Clinic: A Single Institution Experience
BACKGROUND Our tertiary care pediatric hematology/oncology/BMT service receives hundreds of referrals yearly for bleeding disorder evaluation both due to bleeding sy...
Improving the quality of GP referrals to the Croydon Assessment & Liaison Team
Improving the quality of GP referrals to the Croydon Assessment & Liaison Team
AimsTo increase the percentage of GP referrals to the Croydon Assessment & Liaison (A&L) Team deemed to be of ‘good quality’. The A&L Team receives a large number of re...
Bleeding Risk Factors in Thrombocytopenic Patients with Hematologic Malignancies
Bleeding Risk Factors in Thrombocytopenic Patients with Hematologic Malignancies
Introduction Despite prophylactic platelet transfusions, World Health Organization (WHO) grade ≥ 2 bleeding occurs in 50 to 70% of patients with hematologic malignan...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract Introduction Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
The effect of the COVID-19 pandemic on emergency maternal and under-five referrals in Sierra Leone: A cohort study
The effect of the COVID-19 pandemic on emergency maternal and under-five referrals in Sierra Leone: A cohort study
Background In Sierra Leone, the National Emergency Medical Services (NEMS) was designed to facilitate maternal and under-five referrals. During the COVID-19 pandemic, health facili...
Demographic and Clinical Data in 118 Acquired Hemophilia a: Results from a Single Center Study
Demographic and Clinical Data in 118 Acquired Hemophilia a: Results from a Single Center Study
Introduction: Acquired hemophilia A (AHA) is an autoimmune disorder marked by the development of autoantibodies targeting coagulation factor VIII. This rare condi...
Effects of Tranexamic Acid Prophylaxis on Bleeding Outcomes in Hematologic Malignancy: The a-TREAT Trial
Effects of Tranexamic Acid Prophylaxis on Bleeding Outcomes in Hematologic Malignancy: The a-TREAT Trial
Background: Despite optimal prophylactic platelet (plt) transfusion therapy for severe thrombocytopenia in patients undergoing treatment for hematologic malignancy, WHO Grade 2 or ...
Detecting Bleeding Risk in Patients Taking Vitamin K Antagonists Using Thrombin Generation Tests
Detecting Bleeding Risk in Patients Taking Vitamin K Antagonists Using Thrombin Generation Tests
Abstract Introduction: During the last 50 years vitamin K antagonists (VKAs) have been widely used for the primary prevention of thromboembolism in pa...

Back to Top